We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

JXN:NYSEJackson Financial Inc. Analysis

Data as of 2026-05-19 - not real-time

$110.91

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Jackson Financial is trading at $110.91, modestly above its DCF fair value of $106.66, suggesting a slight premium. The stock sits above its 50‑day SMA of 108.09 and the 200‑day SMA of 104.28, confirming a bullish trend, while the 20‑day SMA at 112.2 acts as near‑term resistance. Momentum indicators are mixed: the RSI of 50.8 points to a neutral stance, yet the MACD histogram is negative and the signal line is bearish, hinting at short‑term downside pressure. Volume is on an increasing trend, supporting the price advance, but the beta of 1.35 and 30‑day volatility of 38.8% signal heightened market sensitivity. Fundamentals reveal a low forward P/E of 4.26 versus an industry average of 16.69, a price‑to‑book below 1 (0.79), and a dividend yield of 3.25% with a payout ratio around 43%. The balance sheet is cash‑rich, with cash exceeding debt, and free cash flow of roughly $0.54 B, underpinning dividend sustainability despite a negative profit margin and a revenue decline of 22.6%.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and proximity to 20‑day SMA resistance
  • Strong dividend yield supporting income investors
  • Increasing volume indicating continued market interest

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Undervalued relative to forward earnings and industry multiples
  • Robust cash generation and solid balance sheet
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Stable sector fundamentals in life insurance and annuities
  • Consistent dividend policy providing shareholder returns
  • Potential headwinds from revenue decline and negative profit margins

Key Metrics & Analysis

Financial Health

Revenue Growth-22.60%
Profit Margin-6.31%
P/E Ratio4.3
ROE-3.23%
ROA-0.06%
Debt/Equity51.26
P/B Ratio0.8
Op. Cash Flow$5.2B
Free Cash Flow$537.5M
Industry P/E16.7

Technical Analysis

TrendBullish
RSI50.8
Support$104.52
Resistance$118.20
MA 20$112.20
MA 50$108.09
MA 200$104.28
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair Value$106.66
Target Price$122.00
Upside/Downside10.00%
GradeFair
TypeValue
Dividend Yield3.25%

Risk Assessment

Beta1.35
Volatility38.76%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.